P&G financials
This article was originally published in The Tan Sheet
Executive Summary
Health Care sales advanced 18% to $1.4 bil. in third quarter (ended March 31), fueled by continued strength in oral care business, consumer products firm announces in April 28 1financial release. Price adjustments aimed at positioning Crest Whitestrips more competitively against Colgate Simply White offset a 3% positive currency impact during the period. P&G delayed launch of companion Whitestrips product, Crest Night Effects, from March until end of April because production could not meet retailer demand, firm says. Health Care earnings increased 19% to $147 mil. in Q3...
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.